Comparison of 2 chromogenic media for the detection of extended-spectrum β-lactamase producing Enterobacteriaceae stool carriage in nursing home residents

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 3, 2016, Pages 181-183

  Blane, Beth ^a   Brodrick, Hayley J ^a   Gouliouris, Theodore ^a,b,c   Ambridge, Kirsty E ^a   Kidney, Angela D ^a   Ludden, Catherine M ^a   Limmathurotsakul, Direk ^d   Török, M Estée ^a,b,c   Peacock, Sharon J ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chromogenic agar; Detection; Enterobacteriaceae; Extended spectrum lactamase; Selectivity; Sensitivity

Indexed keywords

CEFPODOXIME; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFTIZOXIME;

AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CITROBACTER; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; NURSING HOME PATIENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CLASSIFICATION; DISK DIFFUSION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; FECES; GENETICS; HETEROZYGOTE; MICROBIOLOGY; NURSING HOME; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; CEFTIZOXIME; DISK DIFFUSION ANTIMICROBIAL TESTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; HUMANS; NURSING HOMES; SENSITIVITY AND SPECIFICITY;

EID: 84958527700     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.11.008     Document Type: Article

References (14)

1. Castanheira M., Farrell S.E., Deshpande L.M., Mendes R.E., Jones R.N. Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother 2013, 57:3012-3020. 10.1128/aac.02252-12.
2. Diederen B., Chang C., Euser S., Stuart J.C. Evaluation of four screening protocols for detection of extended-spectrum β-lactamase-producing members of the Enterobacteriaceae. J Med Microbiol 2012, 61:452-453. 10.1099/jmm.0.036467-0.
3. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe 2013. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2014, ECDC, Stockholm, Sweden, [http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf].
4. Glupczynski Y., Berhin C., Bauraing C., Bogaerts P. Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum β-lactamase-producing Enterobacteriaceae. J Clin Microbiol 2007, 42:501-505. 10.1128/jcm.02221-06.
5. Health Protection Agency UK Standards for Microbiology Investigations. Laboratory detection and reporting of bacteria with extended spectrum β-lactamases 2012, Microbiology services division, HPA, London, UK, [https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/344059/P_2i3.pdf].
6. Huang T.D., Bogaerts P., Berhin C., Guisset A., Glupczynski Y. Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol 2010, 48:2091-2096. 10.1128/jcm.02342-09.
7. Murk J.L., Heddema E.R., Hess D.L., Bogaards J.A., Vandenbroucke-Grauls C.M., Debets-Ossenkopp Y.J. Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units. J Clin Microbiol 2009, 47:1885-1887. 10.1128/jcm.01406-08.
8. Réglier-Poupet H., Naas T., Carrer A., Cady N., Adam J.M., Fortineau N. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases. J Med Microbiol 2008, 57:310-315. 10.1099/jmm.0.47625-0.
9. Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007, 60:913-920. 10.1093/jac/dkm318.
10. Siegel J.D., Rhinehart E., Jackson M., Chiarello L., Healthcare Infection Control Practices Advisory Committee Management of multidrug-resistant organisms in healthcare settings 2006, CDC, Atlanta, GA, [http://www.cdc.gov/hicpac/pdf/guidelines/MDROGuideline2006.pdf].
11. Tumbarello M., Spanu T., Di Bidino R., Marchetti M., Ruggeri M., Trecarichi E.M., et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010, 54:4085-4091. 10.1128/aac.00143-10.
12. Willems E., Cartuyvels R., Magerman K., Verhaegen J. Evaluation of 3 different agar media for rapid detection of extended-spectrum β-lactamase-producing Enterobacteriaceae from surveillance samples. Diagn Microbiol Infect Dis 2013, 76:16-19. 10.1016/j.diagmicrobio.2013.02.013.
13. World Health Organization (WHO) Antimicrobial resistance. Global report on surveillance 2014 2014, WHO, Geneva, Switzerland, [http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1].
14. Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012, 67:2640-2644.